Inferior vena cava diameter in patients with chronic heart failure and chronic kidney disease: a retrospective study

Jianan Li1,2,3, Chi Wang3,4, Hui Wu Dong5

  • 1Medical Big Data Research Center, Medical Innovation Research Division, Chinese PLA General Hospital, 28 Fuxing RD., Beijing, 100853, China.

PubMed

Insights

Elevated inferior vena cava (IVC) diameter is linked to increased mortality risk in patients with chronic heart failure (CHF) and chronic kidney disease (CKD). This association is mediated by N-terminal-pro-B-type natriuretic peptide (NT-proBNP) and serum albumin levels.

Area of Science:

  • Cardiology
  • Nephrology
  • Internal Medicine

Background:

  • Chronic kidney disease (CKD) significantly increases mortality risk in patients with chronic heart failure (CHF).
  • No prior studies have investigated the association between inferior vena cava (IVC) diameter and mortality in patients with concurrent CKD and CHF.

Purpose of the Study:

  • To examine the relationship between IVC diameter and all-cause mortality in patients diagnosed with both CHF and CKD.
  • To investigate the mediating roles of N-terminal-pro-B-type natriuretic peptide (NT-proBNP) and serum albumin in this association.

Main Methods:

  • A retrospective cohort study included 1327 patients with CHF and CKD.
  • Echocardiography data, demographics, medical history, and laboratory tests were collected.
  • Cox regression and mediation analysis were used to assess mortality risk and mediator roles.

Main Results:

  • A total of 757 (57.05%) deaths occurred during a median follow-up of 3.46 years.
  • Increased IVC diameter (>21 mm or as a continuous variable) was significantly associated with higher all-cause and cardiovascular mortality.
  • The association was mediated by NT-proBNP (37.8%) and serum albumin (14.1%).

Conclusions:

  • Elevated IVC diameter is a predictor of worse prognosis in patients with CHF and CKD.
  • NT-proBNP and serum albumin levels partially mediate the link between IVC diameter and mortality in this population.
Abstract

Related Concept Videos

Veins of the Abdomen and Pelvis01:18

Veins of the Abdomen and Pelvis

The human body is a complex system of interconnected parts, and the circulatory system plays a crucial role in maintaining overall health. One key component of this system is the inferior vena cava, a large vein responsible for returning blood from the abdominopelvic viscera and abdominal walls to the heart.
The inferior vena cava is fed by numerous smaller veins. The lumbar veins, for instance, drain the posterior abdominal wall, emptying both directly into the inferior vena cava and into the...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...